☰

Berthony Deslouches, Ph.D. - Publications

Affiliations: 
2005 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Microbiology Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mitra S, Coopershlyak M, Li Y, Chandersekhar B, Koenig R, Chen MT, Evans B, Heinrich F, Deslouches B, Tristram-Nagle S. Novel Helical Trp- and Arg-Rich Antimicrobial Peptides Locate Near Membrane Surfaces and Rigidify Lipid Model Membranes. Advanced Nanobiomed Research. 3. PMID 37476397 DOI: 10.1002/anbr.202300013  0.457
2023 Pereira KE, Deslouches JT, Deslouches B, Woodley SK. In Vitro Investigation of the Antibacterial Activity of Salamander Skin Peptides. Current Microbiology. 80: 214. PMID 37195436 DOI: 10.1007/s00284-023-03320-1  0.536
2022 Allsopp R, Pavlova A, Cline T, Salyapongse AM, Gillilan RE, Di YP, Deslouches B, Klauda JB, Gumbart JC, Tristram-Nagle S. Antimicrobial Peptide Mechanism Studied by Scattering-Guided Molecular Dynamics Simulation. The Journal of Physical Chemistry. B. PMID 36067064 DOI: 10.1021/acs.jpcb.2c03193  0.391
2022 Xiang W, Clemenza P, Klousnitzer J, Chen J, Qin W, Tristram-Nagle S, Doi Y, Di YP, Deslouches B. Rational Framework for the Design of Trp- and Arg-Rich Peptide Antibiotics Against Multidrug-Resistant Bacteria. Frontiers in Microbiology. 13: 889791. PMID 35694289 DOI: 10.3389/fmicb.2022.889791  0.641
2020 Beumera JH, Guo J, Ray EC, Scemama J, Parise RA, Deslouches B, Steckbeck JD, Montelaro RC, Eiseman JL. Mass Balance Study of the Engineered Cationic Antimicrobial Peptide, WLBU2, Following a Single Intravenous Dose of 14C-WLBU2 in Mice. Current Clinical Pharmacology. PMID 32778037 DOI: 10.2174/1574884715666200810094201  0.806
2020 Deslouches B, Montelaro RC, Urish KL, Di YP. Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria. Pharmaceutics. 12. PMID 32486228 DOI: 10.3390/Pharmaceutics12060501  0.76
2020 Mandell JB, A Koch J, Deslouches B, Urish KL. Direct antimicrobial activity of cationic amphipathic peptide WLBU2 against Staphylococcus aureus biofilms is enhanced in physiologic buffered saline. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. PMID 32484998 DOI: 10.1002/Jor.24765  0.58
2020 Di YP, Lin Q, Chen C, Montelaro RC, Doi Y, Deslouches B. Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria. Science Advances. 6: eaay6817. PMID 32426473 DOI: 10.1126/Sciadv.Aay6817  0.765
2020 Heinrich F, Salyapongse A, Kumagai A, Dupuy FG, Shukla K, Penk A, Huster D, Ernst RK, Pavlova A, Gumbart JC, Deslouches B, Di YP, Tristram-Nagle S. Synergistic Biophysical Techniques Reveal Structural Mechanisms of Engineered Cationic Antimicrobial Peptides in Lipid Model Membranes. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 32166806 DOI: 10.1002/Chem.202000212  0.463
2020 Salyapongse A, Penk A, Huster D, Ernst RK, Deslouches B, Di YP, Tristram-Nagle SA. Significance of Secondary Structure Determination When Evaluating Rationally Designed Antimicrobial Peptides Biophysical Journal. 118: 394a. DOI: 10.1016/J.Bpj.2019.11.2241  0.541
2019 Jiang S, Deslouches B, Chen C, Di ME, Di YP. Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α4-Short, in a Murine Model of Respiratory Infection. Mbio. 10. PMID 30967458 DOI: 10.1128/Mbio.00226-19  0.67
2019 Kumagai A, Dupuy FG, Arsov Z, Elhady Y, Moody D, Ernst RK, Deslouches B, Montelaro RC, Peter Di Y, Tristram-Nagle S. Elastic behavior of model membranes with antimicrobial peptides depends on lipid specificity and d-enantiomers. Soft Matter. PMID 30702120 DOI: 10.1039/C8Sm02180E  0.627
2018 Yu Z, Deslouches B, Walton WG, Redinbo MR, Di YP. Enhanced biofilm prevention activity of a SPLUNC1-derived antimicrobial peptide against Staphylococcus aureus. Plos One. 13: e0203621. PMID 30216370 DOI: 10.1371/Journal.Pone.0203621  0.65
2018 Lin Q, Deslouches B, Montelaro RC, Di YP. Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37. International Journal of Antimicrobial Agents. PMID 29753132 DOI: 10.1016/J.Ijantimicag.2018.04.019  0.757
2017 Deslouches B, Di YP. Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections. Clinics in Surgery. 2. PMID 30135956  0.549
2017 Mandell JB, Deslouches B, Montelaro RC, Shanks RMQ, Doi Y, Urish KL. Elimination of Antibiotic Resistant Surgical Implant Biofilms Using an Engineered Cationic Amphipathic Peptide WLBU2. Scientific Reports. 7: 18098. PMID 29273750 DOI: 10.1038/S41598-017-17780-6  0.662
2017 Chen C, Deslouches B, Montelaro RC, Di YP. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of P. aeruginosa pneumonia. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 28882728 DOI: 10.1016/j.cmi.2017.08.029  0.738
2017 Deslouches B, Di YP. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget. PMID 28422728 DOI: 10.18632/Oncotarget.16743  0.588
2017 Hasek ML, Steckbeck JD, Deslouches B, Craigo JK, Montelaro RC. Engineered Cationic Antimicrobial Peptides Containing Cholesterol Interacting Motifs to Target Viral Envelopes Journal of Antivirals & Antiretrovirals. 9. DOI: 10.4172/1948-5964.1000158  0.793
2016 Melvin JA, Lashua LP, Kiedrowski MR, Yang G, Deslouches B, Montelaro RC, Bomberger JM. Simultaneous Antibiofilm and Antiviral Activities of an Engineered Antimicrobial Peptide during Virus-Bacterium Coinfection. Msphere. 1. PMID 27303744 DOI: 10.1128/mSphere.00083-16  0.746
2016 Lashua LP, Melvin JA, Deslouches B, Pilewski JM, Montelaro RC, Bomberger JM. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells. The Journal of Antimicrobial Chemotherapy. PMID 27231279 DOI: 10.1093/Jac/Dkw143  0.723
2016 Deslouches B, Hasek ML, Craigo JK, Steckbeck JD, Montelaro RC. Comparative functional properties of engineered cationic antimicrobial peptides (eCAPs) consisting exclusively of tryptophan and either lysine or arginine. Journal of Medical Microbiology. PMID 27046192 DOI: 10.1099/Jmm.0.000258  0.803
2015 Abdelbaqi S, Deslouches B, Steckbeck J, Montelaro R, Reed DS. Novel engineered cationic antimicrobial peptides display broad-spectrum activity against Francisella tularensis, Yersinia pestis, and Burkholderia pseudomallei. Journal of Medical Microbiology. PMID 26673248 DOI: 10.1099/Jmm.0.000209  0.792
2015 Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Burns JL, Montelaro RC. Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens. Antimicrobial Agents and Chemotherapy. 59: 1329-33. PMID 25421473 DOI: 10.1128/Aac.03937-14  0.796
2014 Steckbeck JD, Deslouches B, Montelaro RC. Antimicrobial peptides: new drugs for bad bugs? Expert Opinion On Biological Therapy. 14: 11-4. PMID 24206062 DOI: 10.1517/14712598.2013.844227  0.803
2013 Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Mietzner TA, Montelaro RC. Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens. Antimicrobial Agents and Chemotherapy. 57: 2511-21. PMID 23507278 DOI: 10.1128/Aac.02218-12  0.815
2007 Deslouches B, Gonzalez IA, DeAlmeida D, Islam K, Steele C, Montelaro RC, Mietzner TA. De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. The Journal of Antimicrobial Chemotherapy. 60: 669-72. PMID 17623696 DOI: 10.1093/Jac/Dkm253  0.685
2005 Deslouches B, Islam K, Craigo JK, Paranjape SM, Montelaro RC, Mietzner TA. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrobial Agents and Chemotherapy. 49: 3208-16. PMID 16048927 DOI: 10.1128/Aac.49.8.3208-3216.2005  0.747
2005 Phadke SM, Deslouches B, Hileman SE, Montelaro RC, Wiesenfeld HC, Mietzner TA. Antimicrobial peptides in mucosal secretions: the importance of local secretions in mitigating infection. The Journal of Nutrition. 135: 1289-93. PMID 15867326 DOI: 10.1093/Jn/135.5.1289  0.758
2005 Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrobial Agents and Chemotherapy. 49: 316-22. PMID 15616311 DOI: 10.1128/Aac.49.1.316-322.2005  0.742
2003 Phadke SM, Islam K, Deslouches B, Kapoor SA, Beer Stolz D, Watkins SC, Montelaro RC, Pilewski JM, Mietzner TA. Selective toxicity of engineered lentivirus lytic peptides in a CF airway cell model. Peptides. 24: 1099-107. PMID 14612179 DOI: 10.1016/J.Peptides.2003.07.001  0.651
Show low-probability matches.